Patients who receive more cells during cell therapy for heart attacks get significant benefits, a new study has suggested. In this study, doctors treated heart attack patients with their own bone marrow cells, selected for their healing potential and then reinjected into the heart, in an effort to improve the heart's recovery. In the PreSERVE-AMI phase II trial, physicians from 60 sites (full author list) treated 161 patients, making the study one of the largest ...
via Medindia Health News More READ
via Medindia Health News More READ
No comments:
Post a Comment